NewAmsterdam Pharma Company N.V.
USD21.37
+0.00 (+0.00%)
CEO
Michael Harvey Davidson Facp.
IPO Date
2021-02-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
NL
Open
$21.37
Prev. Close
$21.37
Day Low
$21.37
Day High
$21.37
52W Low
$8.00
52W High
$30.45
Market Cap
$3.88B
| -10.0 |
| 31 Dec 2023 | FY | 100.0% | -1255.8% | -61.4% | -51.0% | 0.00 | 6.95 | -5.2 |
| 31 Dec 2022 | FY | 100.0% | -22.0% | -5.3% | -4.7% | 0.00 | 13.26 | -9.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -73.8% | -61.5% | 0.00 | 5.96 | -4.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -5.5% | -5.0% | 0.00 | 7.90 | -26.8 |
| -13.4 |
| 30 Sept 2025 | Q3 | 100.0% | -20691.1% | -9.9% | -9.2% | 0.00 | 12.57 | -11.8 |
| 30 Jun 2025 | Q2 | 100.0% | -90.7% | -2.2% | -2.1% | 0.00 | 21.08 | -29.3 |
| 31 Mar 2025 | Q1 | 100.0% | -1327.3% | -5.1% | -4.8% | 0.00 | 19.98 | -15.0 |
| 31 Dec 2024 | Q4 | 100.0% | -721.7% | -12.2% | -10.7% | 0.00 | 8.08 | -6.8 |
| 30 Sept 2024 | Q3 | 100.0% | -57.2% | -4.4% | -3.8% | 0.00 | 10.61 | -23.6 |
| 30 Jun 2024 | Q2 | 100.0% | -1711.6% | -10.1% | -8.7% | 0.00 | 9.83 | -12.5 |
| 31 Mar 2024 | Q1 | 100.0% | -6692.9% | -22.8% | -19.2% | 0.00 | 8.17 | -4.7 |
| 31 Dec 2023 | Q4 | 100.0% | -6163.8% | -17.2% | -14.3% | 0.00 | 6.95 | -4.7 |